Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H23ClN2O2.ClH |
Molecular Weight | 359.291 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | Meso |
SHOW SMILES / InChI
SMILES
Cl.CCN1C[C@@H]2CN(C)C[C@H](C1)[C@@H]2OC(=O)C3=CC=C(Cl)C=C3
InChI
InChIKey=WLBQWCHCDDUUCW-GZADXKAUSA-N
InChI=1S/C17H23ClN2O2.ClH/c1-3-20-10-13-8-19(2)9-14(11-20)16(13)22-17(21)12-4-6-15(18)7-5-12;/h4-7,13-14,16H,3,8-11H2,1-2H3;1H/t13-,14+,16+;
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C17H23ClN2O2 |
Molecular Weight | 322.83 |
Charge | 0 |
Count |
|
Stereochemistry | EPIMERIC |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Bisaramil, an antiarrhythmic drug was developed as an inhibitor of calcium transport and as a membrane stabilizer. In addition, the drug showed tonic and frequency-dependent block that is most potent against the heart Na+ channel. However, the phase-II for Arrhythmias in Japan was discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8116453
Six healthy volunteers received an oral dose of 100 mg and an intravenous dose of 35 mg of bisaramil in a cross over study
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/30594781
In isolated cardiac myocytes bisaramil directly blocks sodium currents with IC50 values of 13μM
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:16:49 GMT 2023
by
admin
on
Sat Dec 16 14:16:49 GMT 2023
|
Record UNII |
AWG1AQA0FC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
AWG1AQA0FC
Created by
admin on Sat Dec 16 14:16:49 GMT 2023 , Edited by admin on Sat Dec 16 14:16:49 GMT 2023
|
PRIMARY | |||
|
96480-44-3
Created by
admin on Sat Dec 16 14:16:49 GMT 2023 , Edited by admin on Sat Dec 16 14:16:49 GMT 2023
|
PRIMARY | |||
|
DTXSID20914493
Created by
admin on Sat Dec 16 14:16:49 GMT 2023 , Edited by admin on Sat Dec 16 14:16:49 GMT 2023
|
PRIMARY | |||
|
135383
Created by
admin on Sat Dec 16 14:16:49 GMT 2023 , Edited by admin on Sat Dec 16 14:16:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |